Atlas Trials

Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma

Clinical trial NCT04640779 · COMPLETED

Trial details

NCT number
NCT04640779
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Histiocytic and Dendritic Cell NeoplasmRecurrent Hodgkin LymphomaRecurrent Non-Hodgkin LymphomaRecurrent Plasma Cell MyelomaRefractory Histiocytic and Dendritic Cell NeoplasmRefractory Hodgkin LymphomaRefractory Non-Hodgkin LymphomaRefractory Plasma Cell Myeloma
Start date
2021-02-08
Primary completion
2025-11-19
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.